SEC Company Response from Tiziana Life Sciences Ltd (TLSA) (CIK 0001723069) (TLSA) — Nov 19, 2018
Tiziana Life Sciences Ltd (TLSA) (CIK 0001723069)
Date: Nov. 19, 2018 · CIK: 0001723069 · Accession: 0001213900-18-016134
AI Filing Summary & Sentiment
File numbers found in text: 333-226368
Show Raw Text
CORRESP
1
filename1.htm
Tiziana
Life Sciences plc
3rd Floor, 11-12 St James’s Square
London SW1Y 4LB
United Kingdom
November
19, 2018
VIA
EDGAR
United
States Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Attention:
Rolf
Sundwall
Mark
Brunhofer
Christine
Westbrook
Suzanne
Hayes
Re:
Tiziana
Life Sciences plc
Acceleration
Request for Post-Effective Amendment No. 1 to Registration Statement on Form F-1
File
No. 333-226368
Ladies
and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Tiziana Life Sciences plc (the “Company”)
hereby requests that the effective date of the above-referenced post-effective amendment No. 1 to the registration statement on
Form F-1 (the “Post-Effective Amendment No. 1 to Registration Statement on Form F-1”) be accelerated to Monday,
November 19, 2018, at 4:00 p.m., Eastern Standard Time, or as soon thereafter as practicable, unless we or our outside counsel,
Cooley (UK) LLP, request by telephone that such Post-Effective Amendment No. 1 to Registration Statement on Form F-1 be
declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities
under the Act.
Once
the Post-Effective Amendment No. 1 to Registration Statement on Form F-1 is effective, please orally confirm the event with our
counsel, Cooley (UK) LLP, by calling Edward Lukins at +44 (0) 20 7556 4261 or Edward Dyson at +44(0) 20 7556 4230.
If
you have any questions regarding this request, please contact our counsel, Cooley (UK) LLP, by calling Edward Lukins at +44 (0)
20 7556 4261 or Edward Dyson at +44(0) 20 7556 4230. Thank you for your assistance with this matter.
Sincerely,
TIZIANA
LIFE SCIENCES PLC
/s/
Kunwar Shailubhai
Kunwar
Shailubhai
Chief
Executive Officer